Cours Advanced Biomedical Technologies, Inc. Other OTC
Actions
ABMT
US00752M1018
Equipement et technologie médicale avancés
CA 2019 | 0,01 0,01 | CA 2020 | 0,12 0,11 | Capitalisation | 10,71 M 9,72 M |
---|---|---|---|---|---|
Résultat net 2019 | - 0 | Résultat net 2020 | - 0 | VE / CA 2019 | 856 383 804 x |
Dette nette 2019 | 5,74 M 5,2 M | Dette nette 2020 | 5,42 M 4,92 M | VE / CA 2020 | 130 476 223 x |
PER 2019 |
-4,48
x | PER 2020 |
-15,3
x | Employés | - |
Rendement 2019 * |
-
| Rendement 2020 |
-
| Flottant | 96,69% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Hui Wang
CEO | Chief Executive Officer | 54 | - |
Kai Gui
DFI | Director of Finance/CFO | 54 | - |
Chi Ming Yu
CHM | Chairman | 50 | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chi Ming Yu
CHM | Chairman | 50 | - |
Hui Wang
CEO | Chief Executive Officer | 54 | - |
Kai Gui
DFI | Director of Finance/CFO | 54 | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+11,28% | 226 Md | |
+9,20% | 188 Md | |
+13,03% | 137 Md | |
+26,10% | 108 Md | |
+0,34% | 63,19 Md | |
+11,86% | 52,26 Md | |
+5,62% | 51 Md | |
+6,54% | 43,89 Md | |
+5,06% | 38,07 Md |